Ligand validation:6KKK

BNG: nonyl beta-D-glucopyranoside

BNG is a Ligand Of Interest in 6KKK designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6KKK_BNG_C_401	27%	33%	0.258	0.907	1.1	1.65	1	6	7	0	100%	1
6KKK_BNG_B_401	22%	32%	0.272	0.891	1.21	1.61	2	7	2	0	100%	1
6KKK_BNG_A_401	18%	29%	0.28	0.865	1.27	1.67	2	4	6	0	100%	1
6KKJ_BNG_B_402	12%	36%	0.324	0.854	0.84	1.76	1	6	0	0	100%	1
6KKL_BNG_A_401	11%	30%	0.246	0.758	0.59	2.28	-	9	5	0	100%	1
6KKI_BNG_A_401	8%	31%	0.328	0.801	1.42	1.46	1	5	0	0	100%	1
4RP9_BNG_A_503	84%	70%	0.091	0.952	0.38	0.76	-	-	3	0	100%	1
4MES_BNG_B_201	72%	51%	0.128	0.953	0.83	1.05	-	2	5	0	100%	1
5B0W_BNG_F_304	71%	49%	0.114	0.934	1.25	0.73	3	-	2	0	100%	1
4MUU_BNG_A_202	70%	42%	0.117	0.934	0.85	1.45	-	6	1	0	100%	0.66
4HHR_BNG_A_714	67%	19%	0.098	0.907	0.83	2.76	2	9	1	0	100%	0.381

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.